David L. Porter

机构：University of Pennsylvania · ORCID：0000-0001-6333-9536

发表论文 448 篇 · 总被引 34994 次 · h-index 62

代表论文

• CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy (2026 · Nature Medicine · 被引 19)
• Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer (2026 · Nature Biomedical Engineering · 被引 9)
• Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas (2026 · New England Journal of Medicine · 被引 2)
• Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis() (2026 · PubMed Central · 被引 1)
• Activity of autologous anti-CD19 chimeric antigen receptor T-cell therapy in CD19-negative large B-cell lymphoma: A cell therapy consortium real world experience (2025 · Blood · 被引 1)
• Publisher Correction: Decade-long persistence of CD19 CAR T cells in B cell lymphomas (2026 · Nature Medicine)